Company Monitoring Page for Gilead

latest headlines for company on cafepharma

Six Things to Watch at Biotech CEO Conference
Minyanville
Mon, 02/11/13 - 11:10 am
Tags:
BIO CEO Conference, ONYX Pharmaceuticals, Celgene, Gilead, Biomarin, Eli Lilly, Keryx, Arena Pharmaceuticals, Orexigen
Gilead Earnings Blaze a Star-Studded Future
Motley Fool
Tue, 02/5/13 - 10:39 am
Tags:
earnings, Gilead
Gilead's 2 hepatitis C drug trials meet study goals
Reuters
Mon, 02/4/13 - 12:17 pm
Tags:
Gilead, hepatitis C, Neutrino, Fission
Gilead Sciences: A Great Long-Term Buy And Heading Bullishly Into Earnings
Seeking Alpha
Sat, 02/2/13 - 11:49 am
Tags:
Gilead, earnings
Gilead Seeks Blood Cancer Drugs to Bolster HIV Business
Bloomberg
Fri, 02/1/13 - 12:06 pm
Tags:
Gilead, HIV, leukemia
Forbes Earnings Preview: Gilead Sciences
Forbes
Wed, 01/30/13 - 01:00 pm
Tags:
earnings, Gilead
Should Gilead's quad pill get an exclusivity extension from FDA?
Fierce Pharma
Fri, 01/25/13 - 10:44 am
Tags:
Quad, Gilead, FDA, HIV
Gilead Petitions FDA Over Its Stribild AIDS Med
Pharmalot
Thu, 01/24/13 - 10:39 am
Tags:
FDA, Stribild, AIDS, Gilead
YM Biosciences says ISS, Glass Lewis endorse Gilead deal
The Fly on the Wall
Fri, 01/18/13 - 10:22 am
Tags:
YM BioSciences, Gilead, M&A
Patients laud Lundbeck, Gilead, but give pharma's rep low marks
Fierce Pharma
Mon, 01/14/13 - 01:15 pm
Tags:
patients, Lundbeck, Gilead
3 Biotech Stocks You Can Buy in 2013
Motley Fool
Fri, 01/4/13 - 11:16 am
Tags:
Gilead, Exelixis, Dendreon
A Bio-Pharmaceutical Trailblazer Up 77% in 2012
Motley Fool
Thu, 01/3/13 - 11:29 am
Tags:
Gilead
13 Biotech Stock Predictions for 2013
TheStreet.com
Wed, 01/2/13 - 12:18 pm
Tags:
Eisai, Sarepta, Arena Pharmaceuticals, Amarin, Gilead, Biomarin, Onyx, Medivation, Achillion, Incyte, Cell Therapeutics, Celgene, NPS Pharmaceuticals, Aegerion, Roche, Biogen Idec, Ariad Pharmaceuticals, Alexza, Navidea, Aveo
Achillion: Poised For Growth And Now Is The Time To Buy
Seeking Alpha
Wed, 01/2/13 - 11:47 am
Tags:
Achillion, Abbott Labs, Bristol-Myers Squibb, Gilead, Merck, Pfizer, Vertex Pharmaceuticals
2 BioPharma Stocks To Consider: Data & Facts
Motley Fool
Fri, 12/28/12 - 11:41 am
Tags:
Abbott Labs, Gilead, Eli Lilly
2012 Roundup -- HCV Treatments
Motley Fool
Fri, 12/28/12 - 11:36 am
Tags:
hepatitis C, Vertex Pharmaceuticals, Gilead, Merck, Abbott Labs, Achillion, GSK, JNJ, Idenix, Bristol-Myers Squibb
Gilead A Strong Buy On New HIV Treatments
Motley Fool
Sat, 12/22/12 - 12:16 pm
Tags:
Gilead, HIV, Stribild
Gilead, Abbott should benefit from first mover HCV advantage, says Wells Fargo
Yahoo/Fly on the Wall
Mon, 12/17/12 - 01:13 pm
Tags:
Gilead, Abbott Labs, hepatitis C
Lessons From The Liver Meeting: Sagient's John Tucker Names Companies That Could Reignite The Hepatitis C Industry
Seeking Alpha
Fri, 11/30/12 - 12:10 pm
Tags:
hepatitis C, Achillion, Gilead, Idenix, Merck, Medivir, Vertex Pharmaceuticals
Teva Won’t Sell Gilead Generics Until June or Ruling
Bloomberg
Wed, 11/28/12 - 10:38 am
Tags:
Teva, generics, Gilead

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.